Cure8 research brief
Why This Matters
Surgical removal of the disease-affected ileocecal segment is common in Crohn’s disease; this study provides regional evidence that laparoscopic ICR can be safe and offers faster recovery compared with open surgery.
Patients and clinicians in similar settings may consider laparoscopy as a preferred approach when expertise and resources are available.
Who Should Pay Attention
Patients with Crohn’s disease facing ileocecal resection; surgeons and surgical teams treating IBD; clinicians counseling surgical options; healthcare planners in low- and middle-income regions.
Study Snapshot
What To Know
This study reports a 17-year, single-center Tunisian experience comparing laparoscopic versus open ileocecal resection (ICR) for primary Crohn’s disease (2004–2020). Of 336 non-recurrent ICRs, 80% were attempted laparoscopically with a 14.9% conversion rate; overall postoperative complications occurred in 9.2% (anastomotic leak most common).
Laparoscopy was linked with faster recovery, shorter hospital stay, and lower analgesic needs, while complication rates were similar between approaches. Low BMI was the only significant predictor of anastomotic fistula. The authors conclude laparoscopic ICR is feasible and safe in this low‑income regional setting.
Keep In Mind
This is a retrospective, single-center study summarized from the article abstract (structured content depth: abstract). Findings reflect the authors’ experience and may be influenced by surgical selection, center expertise, and local resources; randomized trials would be required for causal conclusions.
The abstract reports low overall mortality and complication rates but does not provide long-term recurrence or functional outcomes in the supplied text.
Source Details
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.